Company / Profit Margin
Gain Therapeutics, Inc. Profit Margin History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-40354.3%
FY2024
5-year range
-40354.3% / -8418.9%
FY2021-FY2024
Trend
-221.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -221% YoY in FY2024, a notable deviation from the 3-year average annual change of -80%.
Based on SEC 10-K filings.
-40354.3% in FY2024 with a 3-year CAGR of -27966.7%.
Declined from -8418.9% to -40354.3% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -27966.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, profit margin decreased 221.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -16.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -40354.3% | -221.4% |
| FY2023 | -12555.1% | -49.1% |
| FY2022 | -8418.9% | +32.0% |
| FY2021 | -12387.7% | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026